British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term results.
about
ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trialCurrent therapies in Hodgkin's disease.Long term follow up of topical mustine treatment for cutaneous langerhans cell histiocytosis.Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.Gonadal function in patients treated for Hodgkin's disease in childhood.Outcome in Hodgkin's disease: a 20-year cohort of patients.Treatment outcome of limited stage Hodgkin's disease.The case for adjuvant radiation therapy in advanced Hodgkin's disease.Treatment of elderly Hodgkin's lymphoma patients with a novel 5-drug regimen (ODBEP): a phase II study.MOPP chemotherapy for treatment of resistant lymphoma in dogs: a retrospective study of 117 cases (1989-2000).LOPP chemotherapy as a first-line treatment for dogs with T-cell lymphoma.A pilot study of ChlOPhEPP-B--a weekly regimen for patients with untreated advanced or recurrent Hodgkin's disease.ChlVPP/ABV-VP16 hybrid regimen for advanced Hodgkin's disease: a study in 36 patients.
P2860
Q28365255-E5077987-31C6-448F-8ED2-51805F4266D9Q35117413-C5AE6EFA-BAAB-4285-B68E-FC1B8E5612B5Q35266795-0074946E-731A-4C83-9D6E-120F83CDD667Q35821634-CA0675AB-955B-462A-A805-6D478F6C3562Q36177658-21614184-AA22-45C6-A827-E1A355FDBCBCQ36751817-AA328785-E4B4-4715-8E58-85A900A86598Q37447063-AD3A464D-5F21-4F33-B86D-42BAE6CE74E2Q41020868-E32F17A2-6957-4462-8A99-067B7FC0B6B6Q44058443-8275F6A6-515B-48E8-9C34-62C74B496FB6Q44152109-9422CBED-1341-4D39-A194-8476E9F2EAB5Q48139099-7B2CF92C-B0E8-40A9-8A04-DF85E9ECACCFQ52873547-1CCF068A-1C0D-42A0-A608-EC89C528E1F5Q54098137-5171C5F1-5791-47E4-8FC4-3A7F2ED07CD1
P2860
British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term results.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
British National Lymphoma Inve ...... 's disease--long term results.
@ast
British National Lymphoma Inve ...... 's disease--long term results.
@en
type
label
British National Lymphoma Inve ...... 's disease--long term results.
@ast
British National Lymphoma Inve ...... 's disease--long term results.
@en
prefLabel
British National Lymphoma Inve ...... 's disease--long term results.
@ast
British National Lymphoma Inve ...... 's disease--long term results.
@en
P2093
P2860
P356
P1476
British National Lymphoma Inve ...... 's disease--long term results.
@en
P2093
Bennett MH
Hancock BW
Haybittle JL
Jelliffe AM
MacLennan KA
Vaughan Hudson B
Vaughan Hudson G
P2860
P2888
P304
P356
10.1038/BJC.1991.134
P407
P577
1991-04-01T00:00:00Z